Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleosome assembly protein 1-like 3 (NAP1L3) is a protein encoded by an intronless gene on the human X chromosome. It belongs to the nucleosome assembly protein (NAP) family, whose members are involved in chromatin assembly and organization by facilitating histone and nucleosome dynamics. NAP1L3 is closely mapped to regions associated with several X-linked cognitive disability syndromes, but its mechanistic contribution to such diseases remains unclear. There is no evidence of its function as a receptor, enzyme, transporter, or drug target. Its biological role is generally inferred to be related to nucleosome assembly and chromatin structure rather than direct signal transduction or metabolic activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleosome assembly protein 1-like 3 (NAP1L3).